Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1988 Nov;82(5):1633–1643. doi: 10.1172/JCI113775

Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins.

S H Gianturco 1, A H Lin 1, S L Hwang 1, J Young 1, S A Brown 1, D P Via 1, W A Bradley 1
PMCID: PMC442732  PMID: 3183059

Abstract

Murine P388D1 macrophages have a receptor pathway that binds human hypertriglyceridemic very low density lipoproteins (HTG-VLDL) that is fundamentally distinct from the LDL receptor pathway. Trypsin-treated HTG-VLDL (tryp-VLDL), devoid of apolipoprotein (apo)-E, fail to bind to the LDL receptor, yet tryp-VLDL and HTG-VLDL cross-compete for binding to P388D1 macrophage receptors, indicating that these lipoproteins bind to the same sites. The specific, high affinity binding of tryp-VLDL and HTG-VLDL to macrophages at 4 degrees C is equivalent and at 37 degrees C both produce rapid, massive, curvilinear (receptor-mediated) triglyceride accumulation in macrophages. Ligand blots show that P388D1 macrophages express a membrane protein of approximately 190 kD (MBP190) that binds both tryp-VLDL and HTG-VLDL; this binding is competed by HTG-VLDL, trypsinized HTG-VLDL, and trypsinized normal VLDL but not by normal VLDL or LDL. The macrophage LDL receptor (approximately 130 kD) and cellular uptake of beta-VLDL, but not MBP 190 nor uptake of tryp-VLDL, are induced when cells are exposed to lipoprotein-deficient medium and decreased when cells are cholesterol loaded. Unlike the macrophage LDL receptor, MBP 190 partitions into the aqueous phase after phase separation of Triton X-114 extracts. An anti-LDL receptor polyclonal antibody blocks binding of HTG-VLDL to the LDL receptor and blocks receptor-mediated uptake of beta-VLDL by P388D1 cells but fails to inhibit specific cellular uptake of tryp-VLDL or to block binding of tryp-VLDL to MBP 190. Human monocytes, but not human fibroblasts, also express a binding protein for HTG-VLDL and tryp-VLDL similar to MBP 190. We conclude that macrophages possess receptors for abnormal human triglyceride-rich lipoproteins that are distinct from LDL receptors in ligand specificity, regulation, immunological characteristics, and cellular distribution. MBP 190 shares these properties and is a likely receptor candidate for the high affinity uptake of TG-rich lipoproteins by macrophages.

Full text

PDF
1633

Images in this article

1637Image
on p.1637
1637Image
on p.1637
1638Image
on p.1638
1638Image
on p.1638
1638Image
on p.1638
1639Image
on p.1639
1640Image
on p.1640
1641Image
on p.1641

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aberg H., Lithell H., Selinus I., Hedstrand H. Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris. Results from a 10-year follow-up of Uppsala primary preventive study. Atherosclerosis. 1985 Jan;54(1):89–97. doi: 10.1016/0021-9150(85)90156-x. [DOI] [PubMed] [Google Scholar]
  2. Baker D. P., Van Lenten B. J., Fogelman A. M., Edwards P. A., Kean C., Berliner J. A. LDL, scavenger, and beta-VLDL receptors on aortic endothelial cells. Arteriosclerosis. 1984 May-Jun;4(3):248–255. doi: 10.1161/01.atv.4.3.248. [DOI] [PubMed] [Google Scholar]
  3. Bordier C. Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem. 1981 Feb 25;256(4):1604–1607. [PubMed] [Google Scholar]
  4. Bradley W. A., Gianturco S. H. ApoE is necessary and sufficient for the binding of large triglyceride-rich lipoproteins to the LDL receptor; apoB is unnecessary. J Lipid Res. 1986 Jan;27(1):40–48. [PubMed] [Google Scholar]
  5. Bradley W. A., Hwang S. L., Karlin J. B., Lin A. H., Prasad S. C., Gotto A. M., Jr, Gianturco S. H. Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins. J Biol Chem. 1984 Dec 10;259(23):14728–14735. [PubMed] [Google Scholar]
  6. Brown S. A., Via D. P., Gotto A. M., Jr, Bradley W. A., Gianturco S. H. Apolipoprotein E-mediated binding of hypertriglyceridemic very low density lipoproteins to isolated low density lipoprotein receptors detected by ligand blotting. Biochem Biophys Res Commun. 1986 Aug 29;139(1):333–340. doi: 10.1016/s0006-291x(86)80118-8. [DOI] [PubMed] [Google Scholar]
  7. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  8. Carlson L. A., Böttiger L. E. Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study. Lancet. 1972 Apr 22;1(7756):865–868. doi: 10.1016/s0140-6736(72)90738-6. [DOI] [PubMed] [Google Scholar]
  9. Corthier G., Boschetti E., Charley-Poulain J. Improved method for IgG purification from various animal species by ion exchange chromatography. J Immunol Methods. 1984 Jan 20;66(1):75–79. doi: 10.1016/0022-1759(84)90249-7. [DOI] [PubMed] [Google Scholar]
  10. Daniel T. O., Schneider W. J., Goldstein J. L., Brown M. S. Visualization of lipoprotein receptors by ligand blotting. J Biol Chem. 1983 Apr 10;258(7):4606–4611. [PubMed] [Google Scholar]
  11. Dresel H. A., Otto I., Weigel H., Schettler G., Via D. P. A simple and rapid anti-ligand enzyme immunoassay for visualization of low-density lipoprotein membrane receptors. Biochim Biophys Acta. 1984 Oct 4;795(3):452–457. doi: 10.1016/0005-2760(84)90172-3. [DOI] [PubMed] [Google Scholar]
  12. Ellsworth J. L., Kraemer F. B., Cooper A. D. Transport of beta-very low density lipoproteins and chylomicron remnants by macrophages is mediated by the low density lipoprotein receptor pathway. J Biol Chem. 1987 Feb 15;262(5):2316–2325. [PubMed] [Google Scholar]
  13. Gianturco S. H., Bradley W. A., Gotto A. M., Jr, Morrisett J. D., Peavy D. L. Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages. J Clin Invest. 1982 Jul;70(1):168–178. doi: 10.1172/JCI110590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gianturco S. H., Bradley W. A. The role of apolipoprotein processing in receptor recognition of VLDL. Methods Enzymol. 1986;129:319–344. doi: 10.1016/0076-6879(86)29078-3. [DOI] [PubMed] [Google Scholar]
  15. Gianturco S. H., Brown S. A., Via D. P., Bradley W. A. The beta-VLDL receptor pathway of murine P388D1 macrophages. J Lipid Res. 1986 Apr;27(4):412–420. [PubMed] [Google Scholar]
  16. Gianturco S. H., Gotto A. M., Jr, Bradley W. A. Hypertriglyceridemia: lipoprotein receptors and atherosclerosis. Adv Exp Med Biol. 1985;183:47–71. doi: 10.1007/978-1-4613-2459-1_5. [DOI] [PubMed] [Google Scholar]
  17. Gianturco S. H., Gotto A. M., Jr, Hwang S. L., Karlin J. B., Lin A. H., Prasad S. C., Bradley W. A. Apolipoprotein E mediates uptake of Sf 100-400 hypertriglyceridemic very low density lipoproteins by the low density lipoprotein receptor pathway in normal human fibroblasts. J Biol Chem. 1983 Apr 10;258(7):4526–4533. [PubMed] [Google Scholar]
  18. Goldstein J. L., Brown M. S. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem. 1974 Aug 25;249(16):5153–5162. [PubMed] [Google Scholar]
  19. Goldstein J. L., Ho Y. K., Brown M. S., Innerarity T. L., Mahley R. W. Cholesteryl ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hypercholesterolemic canine beta-very low density lipoproteins. J Biol Chem. 1980 Mar 10;255(5):1839–1848. [PubMed] [Google Scholar]
  20. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Helenius A., Simons K. Removal of lipids from human plasma low-density lipoprotein by detergents. Biochemistry. 1971 Jun 22;10(13):2542–2547. doi: 10.1021/bi00789a019. [DOI] [PubMed] [Google Scholar]
  22. Johnson W. D., Jr, Mei B., Cohn Z. A. The separation, long-term cultivation, and maturation of the human monocyte. J Exp Med. 1977 Dec 1;146(6):1613–1626. doi: 10.1084/jem.146.6.1613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Koo C., Wernette-Hammond M. E., Innerarity T. L. Uptake of canine beta-very low density lipoproteins by mouse peritoneal macrophages is mediated by a low density lipoprotein receptor. J Biol Chem. 1986 Aug 25;261(24):11194–11201. [PubMed] [Google Scholar]
  24. Krul E. S., Tikkanen M. J., Cole T. G., Davie J. M., Schonfeld G. Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins. J Clin Invest. 1985 Feb;75(2):361–369. doi: 10.1172/JCI111708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  26. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  27. Nestel P. J., Billington T., Bazelmans J. Metabolism of human plasma triacylglycerol-rich lipoproteins in rodent macrophages: capacity for interaction at beta-VLDL receptor. Biochim Biophys Acta. 1985 Dec 4;837(3):314–324. doi: 10.1016/0005-2760(85)90055-4. [DOI] [PubMed] [Google Scholar]
  28. Parker F., Bagdade J. D., Odland G. F., Bierman E. L. Evidence for the chylomicron origin of lipids accumulating in diabetic eruptive xanthomas: a correlative lipid biochemical, histochemical, and electron microscopic study. J Clin Invest. 1970 Dec;49(12):2172–2187. doi: 10.1172/JCI106436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Schneider W. J., Beisiegel U., Goldstein J. L., Brown M. S. Purification of the low density lipoprotein receptor, an acidic glycoprotein of 164,000 molecular weight. J Biol Chem. 1982 Mar 10;257(5):2664–2673. [PubMed] [Google Scholar]
  30. Van Lenten B. J., Fogelman A. M., Hokom M. M., Benson L., Haberland M. E., Edwards P. A. Regulation of the uptake and degradation of beta-very low density lipoprotein in human monocyte macrophages. J Biol Chem. 1983 Apr 25;258(8):5151–5157. [PubMed] [Google Scholar]
  31. Van Lenten B. J., Fogelman A. M., Jackson R. L., Shapiro S., Haberland M. E., Edwards P. A. Receptor-mediated uptake of remnant lipoproteins by cholesterol-loaded human monocyte-macrophages. J Biol Chem. 1985 Jul 25;260(15):8783–8788. [PubMed] [Google Scholar]
  32. Via D. P., Plant A. L., Craig I. F., Gotto A. M., Jr, Smith L. C. Metabolism of normal and modified low-density lipoproteins by macrophage cell lines of murine and human origin. Biochim Biophys Acta. 1985 Mar 6;833(3):417–428. doi: 10.1016/0005-2760(85)90099-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES